These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14410483)

  • 1. [First experimental and clinical experiences with eleparon in depot form].
    KOESTLER H
    Med Klin; 1960 Apr; 55():553-4. PubMed ID: 14410483
    [No Abstract]   [Full Text] [Related]  

  • 2. [On further experiences with eleparon in obstetrics. Part 2].
    NIEL W
    Med Klin; 1960 Feb; 55():233-4. PubMed ID: 14427075
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetes and eleparon. Preliminary report on clinical observations].
    HOEHNE HW
    Ther Ggw; 1961 Oct; 100():521-4. PubMed ID: 13908015
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of filiform keratitis with eleparon eyedrops].
    STARK H
    Klin Monbl Augenheilkd Augenarztl Fortbild; 1961 Dec; 139():664-7. PubMed ID: 13916313
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with the immediately acting anticoagulant eleparon in obstetrics].
    NIEL W
    Med Klin; 1959 Jun; 54(26):1209-10. PubMed ID: 13673968
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with Eleparon, a new heparin body].
    MORAWETZ F; SCHNETZ E
    Wien Med Wochenschr; 1962 Apr; 112():300-4. PubMed ID: 14475822
    [No Abstract]   [Full Text] [Related]  

  • 7. [ON THE EFFECT OF ELEPARON IN INTRA-ARTICULAR ADMINISTRATION].
    VIERNSTEIN K
    Med Klin; 1964 Feb; 59():305-9. PubMed ID: 14140197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the use of a heparin concentrate to be administered subcutaneously as an intramuscular depot-heparin].
    KRONBERGER L; CESNIK H
    Med Welt; 1960 Oct; 44():2323-5. PubMed ID: 13754491
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
    Olin DA; Urdaneta F; Lobato EB
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
    Liew G; Campbell C; Thursby P
    ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current treatment concepts in heparin-induced thrombocytopenia].
    Ranze O; Greinacher A
    Dtsch Med Wochenschr; 1999 Jul; 124(28-29):865-73. PubMed ID: 10432950
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed-type skin reaction to the heparin-alternative danaparoid.
    Szolar-Platzer C; Aberer W; Kränke B
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIT/HITT and alternative anticoagulation: current concepts.
    Lakshmanan S; Saha B; Rittoo D
    Br J Anaesth; 2003 Sep; 91(3):445; author reply 445-6. PubMed ID: 12966934
    [No Abstract]   [Full Text] [Related]  

  • 15. [Skin necrosis induced by heparin: apropos of 2 cases].
    Andolfatto S; Latger-Cannard V; Maistre ED; Briquel ME; André E; Montange F; Reichert S; Lecompte T
    Ann Biol Clin (Paris); 2001; 59(5):651-4. PubMed ID: 11602401
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].
    Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with heparin].
    STAMM H
    Chemotherapia (Basel); 1961; 3():344-53. PubMed ID: 13916155
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of heparin-induced thrombocytopenia.
    Greinacher A
    Thromb Haemost; 1999 Aug; 82(2):457-67. PubMed ID: 10605737
    [No Abstract]   [Full Text] [Related]  

  • 19. [Successful lysis therapy of inferior vena cava and iliofemoral venous thrombosis in heparin-induced thrombocytopenia type II].
    Fischer KG
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):32-3. PubMed ID: 9951458
    [No Abstract]   [Full Text] [Related]  

  • 20. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.